56: Vaccination with DC/MM Fusions in Conjunction with Stem Cell Transplantation
Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), D. Avigan, Adam Bissonnette(Dana-Farber Cancer Institute), Robin Joyce(Beth Israel Deaconess Medical Center), C. Lenahan(Beth Israel Deaconess Medical Center), Lynne Uhl(Hadassah Medical Center), Claire MacNamara, Zhourui Wu(Dana-Farber Cancer Institute), Munshi Nc(Dana-Farber Cancer Institute), Donald Küfe(Dana-Farber Cancer Institute), Paul Richardson(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Baldev Vasir(Beth Israel Deaconess Medical Center), Karen Lowe, Katharine K. Miller(Hadassah Medical Center), Dilani Dombagoda(Beth Israel Deaconess Medical Center), KC Anderson, James D. Levine(Beth Israel Deaconess Medical Center)
Cited by 0
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina)
|Nature Biotechnology|2008|1.3k
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2002|1.2k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k